Educated Interests: The Pharmaceutical Money Flowing Through Medical Schools and Into the Regulatory State
Pharmaceutical companies have invested billions of dollars into the medical schools and research institutions that train the scientists, clinicians, and policy officials who will one day evaluate their products for federal approval. A DOE News examination of funding records, curriculum documents, and conflict-of-interest disclosures reveals how deeply industry money has shaped medical education — and what that means for the independence of American health regulation.